Correspondence to Dr Fernando Delgado, Diagnostic and Therapeutical Neuroradiology Unit, Hospital Reina Sofía, Córdoba 14004, Spain; fdelgado.neuro{at}gmail.com Background A stent is often necessary ...
Correspondence to Dr Sibylle Stampfl, Department of Neuroradiology, University Hospital Heidelberg, Im Neuenheimer Feld 400, Heidelberg 69120, Germany; sibylle.stampfl{at}med.uni-heidelberg.de Purpose ...
Correspondence to Dr Matthew J Gounis, Department of Radiology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA; Matthew.Gounis{at}umassmed.edu Background ...
Correspondence to Dr H M Do, Department of Radiology, Interventional Neuroradiology Division, Stanford University Hospital, 300 Pasteur Drive, S0047, Stanford, CA 94305, USA; huymdo{at}stanford.edu ...
Purpose The efficiency of neuroendovascular procedures may partly depend on the time devoted to placement of a radial arterial line (RAL) for intraoperative blood pressure monitoring. An alternative ...
Background and purpose To report clinical and procedural outcomes of acute ischemic stroke patients after endovascular treatment with the new thromboaspiration catheter AXS Catalyst 6. Methods ...
Objective To evaluate the rate of peri-procedural thromboembolic events after the endovascular treatment of cerebral aneurysms. The rate of diffusion-positive lesions was assessed in relation to ...
Correspondence to Dr A Spiotta, Division of Neurosurgery, Department of Neurosciences, Medical University of South Carolina, 96 Jonathan Lucas St, Charleston, SC 29425, USA; spiotta{at}musc.edu ...
1 Department of Neurological Sciences, Division of Diagnostic and Interventional Neuroradiology, University Hospital of Siena, Italy Background and purpose Aspiration thrombectomy of large vessel ...
Introduction Middle meningeal artery (MMA) embolization is becoming an increasingly established treatment option for chronic subdural hematoma (cSDH). Although several systematic reviews have ...
Background The Pipeline Vantage Embolization Device with Shield Technology is a next generation flow diverter developed to improve aneurysm occlusion and implant endothelialization in addition to ...
Introduction The Vecta46 intermediate catheter, recently approved by the FDA, introduces a mini-triaxial access system designed to accommodate 0.058’ guides, 0.027’ microcatheters, and allows ...